Background: Mutations in the Fe-S cluster-containing SDHB subunit of succinate dehydrogenase cause familial cancer syndromes. Recently the tripeptide motif L(I)YR was identified in the Fe-S recipient protein SDHB, to which the cochaperone HSC20 binds.
article
Warburg effect in cancer (2) . While patients with germline FH mutations are at risk for the development of cutaneous and uterine leiomyomas and an aggressive form of type 2 papillary kidney cancer characterized by a metabolic shift to aerobic glycolysis and glutamine-dependent reductive carboxylation (3, 4) , those with germline mutations in succinate dehydrogenase are at risk for the development of paragangliomas, pheochromocytomas, gastrointestinal stromal tumors (GIST), as well as an aggressive form of oncocytic kidney cancer (SDH-RCC) (5) (6) (7) (8) .
Succinate dehydrogenase, which functions as complex II in the mitochondrial respiratory chain, is a complex made up of SDHA, SDHB, SDHC, and SDHD subunits. SDHA couples the oxidation of succinate to fumarate with the reduction of covalently bound FAD+ to FADH 2 . Three iron-sulfur (Fe-S) clusters in SDHB facilitate transfer of electrons from FADH 2 to ubiquinone, which is bound via the membrane-embedded SDHC and SDHD subunits (9) . We recently showed that succinate dehydrogenase assembly and function are dependent on two highly conserved L(I)YR motifs in SDHB, which confer critical specificity for iron sulfur cluster delivery. The pathogenic mutation SDHB R46Q alters the first L(I)YR motif by changing IYR to IYQ and causes impaired Fe-S cluster incorporation into SDHB, thus rendering the protein unstable (10) .
Here we report the characterization of an SDHB-deficient renal cell carcinoma cell line from a young patient carrying the SDHB R46Q mutation, which was used to explore the altered metabolism of SDH-deficient cancers and gain mechanistic insights into the delivery of Fe-S clusters to SDHB. Metabolic profiling demonstrated a metabolic shift to aerobic glycolysis as well as dependence on reductive carboxylation of glutamine-derived carbon in the TCA cycle. Finally, a systematic biochemical and bioinformatic analysis of reported SDHB cancer-causing missense mutations in neuroendocrine and renal tumors revealed that residues involved in acquisition or ligation of Fe-S clusters accounted for a high percentage of SDHB-related tumors.
Methods

Patient Characteristics
The patient, who was evaluated at the National Institutes of Health on a Urologic Oncology Branch, National Cancer Institute (NCI) protocol approved by the NCI Institutional Review Board, gave written informed consent for participation in this study. The clinical course and presentation of this patient are described in the Supplementary Materials (available online) and have been described previously (8) .
Tissue Culture Procedures
See the Supplementary Materials (available online).
Native PAGE (BN-PAGE) and Immunoblot
The NativePAGE Novex Bis-Tris gel system (Invitrogen, Carlsbad, CA) was used for the analysis of native membrane protein complexes and native mitochondrial matrix complexes, with several modifications, as already described (10) . Anti-SDHA and SDHB antibodies were from Mitosciences (Eugene, OR), and rabbit antiTom20 was from Santa Cruz Biotechnology (Santa Cruz, CA).
In-Gel and Spectrophotometric Complex II Activities
Detailed protocols can be found in the Supplementary Methods (available online). Complex II (SQR) activity in whole-cell extracts was measured using a microplate assay from Abcam (Cambridge, UK).
Seahorse and Metabolic Tracer Analysis
Statistical Analysis
Statistical analysis was performed using parametric unpaired, two-tailed t tests with 99% confidence intervals, and P values of less than .05 were considered statistically significant. All error bars presented in this work represent standard deviation.
Results
UOK269: A Renal Cell Carcinoma Cell Line
Characterized by an R46Q Mutation in the IYR Motif of SDHB Mutations in mitochondrial complex II genes SDHB, SDHC, and SDHD have recently been found to cause the familial kidney cancers, which are characterized by an early onset of disease and highly aggressive growth (6, 8) . A radical nephrectomy was performed on a woman age thirty-two years to remove a 5.2 cm T3aN0M1 renal tumor ( Figure 1A ) (see the Supplementary Materials, available online), which showed oncocytic morphology ( Figure 1B) (8) . The patient died of widely metastatic kidney cancer six months after surgery. A kidney cancer cell line, UOK269, was established following surgical excision of the tumor ( Figure 1C ). Germline sequencing of candidate familial kidney cancer-causing genes identified a heterozygous point mutation (CGA to CAA) in the SDHB gene, resulting in a codon change at the conserved amino acid position 46 (R46Q) ( Figure 1D ). Genetic testing of the patient's family members revealed that the patient's father and paternal aunt, the latter of whom had a history of paraganglioma, carried the R46Q mutation (8) . The patient's tumor and tumor-derived UOK269 cell line showed loss of the remaining wild-type SDHB allele and retention of only the SDHB mutated allele ( Figure 1D ). Importantly, the R46Q mutation occurs in the first L(I)YR motif of SDHB, which was recently shown to be critical for acquisition of Fe-S clusters in SDHB and for subsequent incorporation of SDHB into mitochondrial complex II (10) .
To evaluate expression of SDHB R46Q in the SDH-RCC patient's tumor, western blot analyses were performed on tumor extracts derived from the patient harboring the R46Q mutation, as well as from the tumor of a patient who harbored a germline SDHB nonsense mutation, which caused premature truncation at amino acid residue R90, SDHB R90* ( Figure 1E ). Both tumors showed dramatic reduction of SDHB protein levels as compared with normal kidney tissue, despite ample expression of the separately encoded SDHA subunit of respiratory complex II ( Figure 1E ).
Tumors with SDHx mutations have recently been shown to have a global DNA CpG island methylator phenotype (CIMP) attributed to the product-level inhibition of demethylases such as TET2 by elevated succinate (11, 12) . The methylation status of the UOK269 cells was evaluated using the Illumina HumanMethylation450 BeadChip array and compared with cultured primary human renal cortical epithelial (HRCE) cells. Differential methylation values for each of the approximately 150 000 Illumina probes positioned within CpG islands were calculated by subtracting the β-values of the control probe article (HRCE) from β-values of the UOK269 probe. A positive differential methylation value of 0.5 or highger was considered to represent hypermethylation and identified 17 004 distinct CpG island probes in UOK269 (11%) ( Figure 1F ). Conversely, a negative differential methylation value of -0.5 or less was considered to represent hypomethylation and identified only 135 distinct CpG island probes in UOK269. Increased methylation was also observed in regions outside of CpG islands. These results support the presence of a hypermethylation phenotype in UOK269 cells. Furthermore, cluster analysis of the 17 004 hypermethylated CpG island probes in UOK269, performed by comparing UOK269 to two normal kidney renal cortex tissue DNA samples obtained from the TCGA clear cell RCC analysis (13) , suggested that DNA hypermethylation in UOK269 cells may be an aberrant phenotype related to SDH deficiency, as this pattern was not present in the normal tissue ( Figure 1G ).
Evaluation of Metabolic Parameters and HIF1α Expression in UOK269 Cells
Loss of enzymatic components of the TCA cycle is expected to impair oxidative phosphorylation, and decreased oxygen consumption has been observed in tumor-derived cells harboring mutations in the gene for the TCA cycle enzyme fumarate hydratase (14) . Analysis of complex II activity demonstrated a profound lack of succinate dehydrogenase (SDH) activity in SDHB-deficient UOK269 cells (mean±SD; 0.25 ± 0.04 decrease in absorbance at 600 nm per minute per mg cellular protein; UOK269 vs HEK293 P < .01), as compared with HEK293 cells (mean±SD; 14.16 ± 1.62 decrease in absorbance at 600 nm per minute per mg cellular protein) or UOK269 cells engineered to stably express wild-type SDHB gene by lentiviral transduction (UOK269WT; mean±SD 10.13 ± 2.02 decrease in absorbance at 600 nm per minute per mg cellular protein; UOK269WT vs HEK293 P > .05) (Figure 2A ). Complex II activity was not restored in UOK269 cells transfected with the backbone vector lacking the SDHB gene (UOK269EV; mean±SD; 0.39 ± 0.24 decrease in absorbance at 600 nm per minute per mg cellular protein; UOK269EV vs HEK293 P < .01) (Figure 2A ). Oxygen consumption, measured by Seahorse Flux Analyzer, in SDHB-deficient UOK269 cells was below the limits of detection ( Figure 2B ). UOK269 cells showed strong, glucose-stimulated acidification of the culture medium ( Figure 2C ), suggesting that these cells rely heavily on glucose metabolism and lactic acid production for growth and cell division. In contrast, UOK269WT and HEK293 cells, which have intact mitochondrial complex II, showed increased respiration (oxygen consumption rate) 
cm mass on the left kidney (white arrow). B)
The patient underwent a radical nephrectomy and pathologic examination revealed that the tumor had oncocytic morphology, as described previously (8) . Scale bar = 50 µm. C) A cultured explant from the tumor yielded the continuous cell line, UOK269.
Scale bar = 10 µm. D) Genomic DNA sequencing revealed that the patient harbored a heterozygous germ-line point mutation (R46Q) in the SDHB gene and that both the tumor and the tumor-derived cell line UOK269 showed loss of heterozygosity at this allele, whereas both the normal G residue and the abnormal A transition were detectable in somatic DNA derived from the patient's blood. E) Western blot analyses of extracts made from normal kidneys and from this patient's tumor (R46Q) as well as an unrelated tumor (R90*) also harboring a premature stop codon in sdhb revealed that both tumors showed a profound loss of SDHB protein, whereas the complex II subunit, SDHA, was still present in the tumors. The ponceau S-stained membrane served as a loading control for assessment of total protein levels. F) CpG island methylation status was compared between DNA extracts of UOK269 and HRCE cells using the Illumina HumanMethylation450 BeadChip array. The number of distinct CpG island probes showing increased differential methylation in UOK269 (calculated as the UOK269 β-value minus the HRCE β-value) of 0.5 or higher, indicating hypermethylation, are shown graphed in intervals of 0.1. G) Comparison of the 17 004 CpG island probes hypermethylated in UOK269 vs normal kidney renal cortex tissue was visualized using cluster analysis. H&E = hematoxylin and eosin. article and lower glycolytic activity (extracellular acidification rate) ( Figure 2D ).
Recently, there has been growing appreciation of the ability of specific cellular metabolites to act as pro-oncogenic factors that can stimulate carcinogenesis (2). Succinate is one such 'oncometabolite' because elevated cellular succinate can cause inhibition of a class of iron-and α-ketoglutarate-dependent dioxygenases, the prolyl hydroxylases (PHDs), which are responsible for targeting hypoxia inducible factors HIF1α and HIF2α for degradation (15) . Consistently, we found greatly elevated HIF1α protein levels in nuclear extracts from SDHB-deficient UOK269 cells as compared with HEK293 cells and UOK269WT cells, in which SDH activity was restored ( Figure 2E ). The human fibroblast cell line MCH46 depleted of iron by treatment with the chelator desferrioxamine (DFO) served as a positive control for identification of elevated HIF1α because of stabilization of the protein through inhibition of the PHDs enzymatic reaction ( Figure 2E ). HIF2α expression in nuclear extracts from UOK269 cells did not change compared with UOK269WT, HEK293, or fibroblast cell lines. MCH46 fibroblasts grown in the presence of low oxygen for six hours served as the positive control. Together, these data suggest that elevated HIF1α levels in SDHB-deficient UOK269 cells might be caused by inhibition of the PHDs-mediated degradation of HIF1α because of high intracellular succinate.
Sources of TCA Cycle Intermediates in SDHBDeficient UOK269 Cells
Tumors rely on glucose and glutamine for energy production and biosynthesis of the macromolecules necessary for continuous proliferation (16) . Given the pivotal role of SDH as the interface between the TCA cycle and the mitochondrial respiratory chain, we evaluated TCA cycle metabolite levels using stable isotope-resolved metabolomics. We observed dramatically high levels of intracellular succinate in UOK269 cells (n = 3, mean±SD, 351.4 ± 63.2 nmol/mg protein) ( Figure 3A) , as well as secretion of succinate into the culture medium ( Figure 3B Figure 3B ), whereas extracellular lactate was produced exclusively from 13 C 6 -glucose ( Figure 3C ). These findings demonstrate that glucose is preferentially directed toward lactic acid fermentation and secretion, whereas secreted succinate is derived from glutamine in SDHB-deficient UOK269 cells.
Next, we utilized 1D-heteronuclear single quantum coherence nuclear magnetic resonance (HSQC NMR) spectroscopy to examine the distribution of intracellular metabolites in SDHB-deficient UOK269 cells following growth for 24 hours in the presence of either Figure 3D ). These data demonstrated that glucose-derived 13 C-glucose-derived carbons were incorporated into lactate, alanine, nucleotides, and glycogen, whereas the TCA-derived intermediates glutamate, succinate, and glutathione (which contains glutamate) derived their carbons from 13 C-glutamine. GC-MS analysis of isotopologues of succinate (E), malate (F), fumarate (G), aspartate (H), and citrate (I) in UOK269 cell extracts grown in the presence of 13 C 6 -glucose, 13 C 5 , 15 N 2 -glutamine, or singly labeled 13 C 1 -glutamine for 24 hours underscored that glutamine was the dominant carbon source for these metabolites. J) Schematic diagram illustrates that glucose was mainly converted to lactate, alanine, nucleotides, and glycogen, whereas glutamine was a dominant carbon source of TCA cycle intermediates. article ( Figure 3D ). Analysis of these stable isotope-labeled UOK269 cell extracts using gas chromatography-mass spectrometry (GC-MS) further demonstrated that the highly elevated intracellular succinate in SDHB-deficient UOK269 cells was derived nearly exclusively from glutamine, as incubation of UOK269 cells with 13 C 5 , 15 N 2 -glutamine resulted in fully labeled (m+4) intracellular succinate. Singly labeled 13 C-1-glutamine did not label succinate ( Figure 3E ), indicating that the 13 C label was lost as carbon dioxide (CO 2 ) during the α-ketoglutarate dehydrogenase reaction. In contrast, incubation of UOK269 cells with 13 C-1-glutamine resulted in robust m+1 labeling of malate, aspartate, fumarate, and citrate, indicating that glutamine was likely incorporated into citrate by reductive carboxylation of glutamine-derived α-ketoglutarate through the activity of isocitrate dehydrogenase ( 
Functional Analysis of Disease-Causing SDHB Mutations
The metabolic analyses described above demonstrate the remarkable ability of SDH-deficient human renal cancer cells to adapt to the loss of a crucial component of the TCA cycle and the mitochondrial respiratory chain. An understanding of SDHrelated tumorigenesis is crucial because mutations in succinate dehydrogenase genes, including SDHB, increase susceptibility to development of paragangliomas and pheochromocytomas (17, 18) , renal cell carcinoma (6, 8) , and gastrointestinal stromal tumors (19) . SDHB is the Fe-S subunit of Complex II and contains two highly conserved L(I)YR motifs that are essential for acquisition of Fe-S clusters by recruiting the Fe-S transfer machinery (10) . We searched the Leiden Open Variation Database (LOVD) (20) for germline oncogenic missense mutations in SDHB that affect amino acid residues that are important for Fe-S cluster acquisition (L(I)YR motif amino acid residues) or ligation (cysteines). The 3D structure of porcine SDHB(9) (Figure 4A ), which is 96% identical to human SDHB, shows the position of the two L(I)YR motifs and the three Fe-S clusters, which are also highlighted in the primary sequence of human SDHB ( Figure 4B ). In order to evaluate whether oncogenic mutations clustered near residues involved in acquisition or ligation of the Fe-S clusters, we catalogued the number and position of SDHB missense mutations. Notably, missense mutations of residues in the first (I 44 Y 45 R 46 ) and in the second (L 240 Y 241 R 242 ) L(I)YR motifs accounted for 12% of reported tumors. Mutations of the cysteinyl ligands of the first, second, and third Fe-S clusters accounted for an additional 8%, 12%, and 5% of tumors, respectively ( Figure 4C ). Altogether, mutations in the L(I)YR motifs or cysteinyl ligands accounted for 37% of families, whereas other mutations were located more diffusely across the SDHB primary sequence ( Figure 4C ). The occurrence of renal cell carcinomas (SDH-RCCs) and gastrointestinal stromal tumors (GISTs) is less frequent than that of pheochromocytomas and paragangliomas in patients with SDHB mutations and can be considered a more aggressive phenotype. Analyses of reported missense mutations that affected the L(I)YR motifs or the cysteinyl ligands in patients with SDH-RCC or GIST revealed that 50% of these patients had SDHB mutations in the L(I)YR motif amino acid residues (Supplementary Figure 2 , available online).
L(I)YR Mutations and SDH Complex Assembly and Activity
Analyses of the UOK269 cell line and tumor material harboring the homozygous SDHB R46Q mutation revealed that SDH activity was lost (cell line) ( Figure 2A ) and SDHB protein was undetectable (tumor) (Figure 1 ). Therefore, we used UOK269 cells as an experimental system that lacked SDHB and SDH activity to express and characterize reported SDHB pathogenic mutations of the L(I)YR motif amino acid residues or of the Fe-S clusterligating cysteines (Table 1) . Expression of SDHB I44N , which harbors a mutation in the first L(I)YR motif of SDHB and has been reported to cause GIST (21) , was unable to restore SDH activity in UOK269 cells ( Figure 5A ). In contrast, UOK269 cells transfected with wild-type SDHB (+SDHB) ( Figure 5A ) revealed robust SDH activity. As SDHB acquires its Fe-S clusters before forming a functional complex with SDHA, SDHC, and SDHD (10), we used Blue Native-PAGE (BN-PAGE) analysis and immunoblotting (IB) of mitochondrial extracts to assess the various stages of complex II assembly. We found no evidence of mature complex II (CII) formation in UOK269 cells transfected with SDHB I44N (Figure 5B ), though an assembly intermediate, termed CIIb, was detected, which was previously shown to contain HSC20, ISCU, and HSPA9 (10) . Importantly, the second LYR motif in SDHB I44N was intact. Nevertheless, SDHB I44N failed to incorporate its Fe-S clusters and did not progress into formation of a complex with SDHA (CIIa). Interestingly, steady-state protein levels of SDHB I44N were reduced compared with wild-type SDHB or to other mutants ( Figure 5C ). SDHB
R242C
, harboring a substitution of the arginine into cysteine in the second L(I)YR motif of SDHB, was also unable to incorporate into a functional complex or restore SDH activity ( Figure 5, A and B) . Interestingly, levels of SDHB R242C protein were higher than those of SDHB I44N , consistent with the previously reported instability of SDHB mutants harboring mutations in the first IYR motif ( Figure 5C ) (10) .
Cysteine Mutations and SDH Complex Assembly and Activity
We also tested the effects on SDH assembly and activity of mutations of the cysteines that ligate each of the three Fe-S clusters ( Figure 6A) . None of the SDHB mutants harboring cancer-causing mutations in the Fe-S cluster-ligating cysteines exhibited any succinate-coenzyme Q reductase (SQR) activity ( Figure 6A ). The native immunoblots for SDHB protein also demonstrated that none of the SDHB mutants progressed to association with SDHA (complex CIIa) or to full SDH complex formation (CII) ( Figure 6B) . Nevertheless, the transfected missense proteins Figure 6C ). Finally, quantitative spectrophotometric assay of SDH activity in mitochondrial extracts from UOK269 cells expressing the SDHB cancer-causing mutations in L(I)YR motifs or in the cysteines revealed that none of the mutants was able to restore SDH activity ( Figures 6D;  Supplementary Figure 1 , available online). Our biochemical and functional characterization of cancer-causing missense mutations affecting the L(I)YR motifs or the Fe-S cluster cysteinyl ligands of SDHB demonstrated the detrimental effects of mutations, which occur in positions that are crucial for biogenesis of SDHB and assembly of the SDH complex.
Discussion
Alteration of cellular metabolism is a hallmark of cancer, contributing to its initiation, growth, and progression (22, 23) . Recent studies have shown that renal cancer is associated with mutations of specific genes that affect cellular metabolism (23, 24) . Clear examples of this are the hereditary cancer syndromes characterized by germline mutation of the genes for the TCA cycle enzymes fumarate hydratase (FH) and succinate dehydrogenase (SDH) (6, 25) . In the present study, we evaluated the role of cancer-causing SDHB mutations that impair the delivery of Fe-S clusters into the SDHB protein. We developed an SDHB-deficient cell line derived from a kidney tumor that was surgically removed from a patient carrying a germline SDHB R46Q mutation that lies in the first L(I)YR motif required for incorporation of the Fe 2 -S 2 cluster into SDHB. The pronounced decrease in SDHB activity in these tumor-derived SDHB R46Q cells led to a metabolic shift characterized by aerobic glycolysis, a total absence of detectable mitochondrial respiration, as well as markedly elevated HIF1α protein levels, all of which were restored with re-expression of SDHB. These results suggest that, similar to our findings in FH-deficient kidney cancer (4), HIF1α is the predominant HIF in SDH-deficient kidney cancer (and that HIF2α protein levels are unaffected by the elevated succinate levels in UOK269 cells).
We have previously shown that FH-deficient kidney cancer is characterized by glutamine-dependent reductive carboxylation, which is critical for increased fatty acid production needed for rapid cellular growth (3) . In the present study we utilized stable isotope-resolved metabolomics to examine the metabolic effects of loss of SDHB in UOK269 kidney cancer cells and found substantial increases in both intracellular as well as article extracellular succinate, which is consistent with the phenotype of SDHx-mutated paragangliomas and pheochromocytomas (26, 27) . In addition, SDHB-deficient renal cell carcinoma was also characterized by glutamine-dependent reductive carboxylation. M+3 labeling of malate, fumarate, and aspartate in UOK269 cells labeled with Figure 3J) . Nascent Fe-S clusters are assembled on the main scaffold protein ISCU and subsequently transferred to recipient proteins such as SDHB by a dedicated chaperone-cochaperone system consisting of the HSPA9-HSC20 pair (4). We recently found that the cochaperone HSC20 facilitates delivery of Fe-S clusters to specific recipients, including SDHB, by directly binding the L(I) YR tripeptide motif present in Fe-S proteins or in accessory factors that assist biogenesis of Fe-S proteins (10) . The two L(I)YR motifs in SDHB engage the HSC20-HSPA9-holo-ISCU complex to facilitate incorporation of three Fe-S clusters into complex II (10) . Mutations of the two L(I)YR motifs, or the eleven Fe-S cluster cysteinyl ligands, were frequent causes of SDHB-related cancers, accounting for 37% of the tumors thus far described in association with SDHB mutations. The biochemical characterization of the SDHB mutants harboring disease-causing mutations in either of the two L(I)YR sequences or in the eleven Fe-S cluster-ligating cysteines revealed that the mutations impaired biogenesis of SDHB by preventing acquisition of its prosthetic groups. Because the Fe-S clusters are crucial for electron transport and function, it is not surprising that these mutations completely abrogate SDH activity.
The prevalence of missense mutations in the two L(I)YR motifs of SDHB in familial paraganglioma/pheochromocytoma/ GIST/renal cell carcinoma tumor syndromes underscores the importance of this recently identified motif (10) . Although these article findings offer important organizing principles for understanding SDHB-dependent tumorigenesis, a number of questions remain, including the extent to which succinate-mediated competitive inhibition of 2-oxoglutarate-dependent dioxygenases, including prolyl hydroxylases, a subset of histone demethylases in the JMJD family, and the ten-eleven translocation (TET) family of 5-methyl cytosine (5 mC) family of hydroxylases, contribute to the SDHdeficient tumor phenotype (28) . Potential succinate-induced changes include stabilization of HIF1α (15) and hypermethylation of histones and DNA (11, 12) . Notably, UOK269 cells show a DNA hypermethylation phenotype similar to that observed in other SDHx tumors (11, 12, 29) and a marked elevation of HIF1α.
One limitation of the present study is that not all diseasecausing SDHB missense mutations were tested for their ability to reconstitute complex II assembly and activity in UOK269 cells. It remains to be determined whether some tumorigenic SDHB mutations, such as those that do not affect either the L(I) YR Fe-S transfer motifs or one of the eleven Fe-S cluster-ligating cysteines of SDHB, could result in some level of residual SDH activity that may be reflected in the clinical phenotype. Further in vitro and in vivo biochemical and metabolic analyses of the familial cancer syndromes associated with deficiency of the enzymes of intermediary metabolism will hopefully lead to the identification of novel functions of TCA cycle metabolites and provide the foundation for the development of therapeutic approaches for these and related cancers.
